Login to South West London Pathology Services

If you have any queries about pathology consumables – you need a new account or you have a query about your order, please telephone 020 8266 6827. Forgotten your password

Patient consent

In order to take a patient’s blood or other bodily sample it is necessary to obtain the patient’s

It is the responsibility of the clinician to ensure the patient understands the reason for making
the request for an examination and the range of tests that may be involved. The reasons for
investigation should be explained clearly to the patient.

The initial consent is likely to involve a request to investigate what is wrong, rather than to
perform a specific set of analyses. Clinicians must also consider whether or not to document
the consent they have obtained.

General Medical Council guidance states that discussions with patients should be tailored
according to:

  • their needs and wishes
  • their level of knowledge about, and understanding of, their condition, prognosis and
    the treatment options
  • the nature of their condition
  • the complexity of the treatment
  • the nature and level of risk associated with the investigation or treatment.

Patients can give consent orally or in writing, or they may imply consent by complying with
the proposed examination or treatment, for example, by rolling up their sleeve to have their
blood sample taken.

Latest news

April 5, 2024

SWLP awards major blood sciences contract to Beckman Coulter

At the beginning of the year, South West London Pathology (SWLP) was delighted to award a major clinical blood sciences (CBS) contract for all SWLP sites to global leader in clinical diagnostics Beckman Coulter.

Read more
April 5, 2024

Cellular Pathology managed service contract awarded to Leica Biosystems

At the end of 2023, South West London Pathology (SWLP) awarded a managed service contract for histopathology to Leica Biosystems.

Read more
April 4, 2024

A day in the life… Faizur Rehman

Find out more about SWLP’s fantastic Deputy Head of IT Faizur Rehman and what a standard day looks like for him…

Read more
March 12, 2024

Beta D Glucan (BDG) testing brought in-house

At the end of last year, testing for Beta-D-Glucan (BDG) was brought in-house. The median turnaround time using the new in-house assay is around two days, which facilitates a greater impact on antifungal stewardship when the result is negative.

Read more